Spruce Biosciences Announces Data Presentation at the 18th International MPS Symposium
Stocks in this Quantisnow insightHealth Care
Historical context for SPRB
Across the 18 sessions after earlier SPRB headlines, the stock closed higher 10 times and lower 8 times, with a median move of 2.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | SPRB | SPY |
|---|---|---|---|
| May 28, 2026 | Spruce Biosciences to Participate in Upcoming Conferences in June | -0.7% | +0.6% |
| May 13, 2026 | Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates | +1.6% | +0.6% |
| May 4, 2026 | Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations | +3.6% | -0.4% |
| Apr 27, 2026 | Craig Hallum initiated coverage on Spruce Biosciences with a new price target | +5.2% | +0.2% |
| Apr 21, 2026 | Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrantsand 1 other headline that session | -26.0% | -0.7% |
| Mar 9, 2026 | Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updatesand 1 other headline that session | +11.2% | +0.9% |
Quantisnow market dataNASDAQ
SPRB
Spruce Biosciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for SPRB
Full SPRB profile on Quantisnow Follow SPRB and get a push notification the moment its next story breaks.